0001567619-21-006960.txt : 20210325
0001567619-21-006960.hdr.sgml : 20210325
20210325163649
ACCESSION NUMBER: 0001567619-21-006960
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180924
FILED AS OF DATE: 20210325
DATE AS OF CHANGE: 20210325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karas Kevin R
CENTRAL INDEX KEY: 0001522907
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35929
FILM NUMBER: 21772869
MAIL ADDRESS:
STREET 1: C/O NATIONAL RESEARCH CORPORATION
STREET 2: 1245 Q STREET
CITY: LINCOLN
STATE: NE
ZIP: 68508
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NATIONAL RESEARCH CORP
CENTRAL INDEX KEY: 0000070487
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 470634000
STATE OF INCORPORATION: WI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1245 Q STREET
CITY: LINCOLN
STATE: NE
ZIP: 68508
BUSINESS PHONE: 4024752525
MAIL ADDRESS:
STREET 1: 1245 Q STREET
CITY: LINCOLN
STATE: NE
ZIP: 68508
4
1
doc1.xml
FORM 4
X0306
4
2018-09-24
0
0000070487
NATIONAL RESEARCH CORP
NRC
0001522907
Karas Kevin R
C/O NATIONAL RESEARCH CORPORATION
1245 Q STREET
LINCOLN
NE
68508
0
1
0
0
SVP Finance, CFO, Treas & Secy
Common Stock
2018-09-24
4
S
0
3700
38.2286
D
10684
D
Common Stock
2018-09-24
4
S
0
300
39.0583
D
10384
D
Common Stock
2021-03-23
4
M
0
5334
18.80
A
15718
D
Common Stock
2021-03-23
4
M
0
19313
13.17
A
35031
D
Common Stock
2021-03-23
4
F
0
12735
45.55
D
22296
D
Employee Stock Option (Right to Buy)
18.80
2021-03-23
4
M
0
5334
0
D
2024-01-07
Common Stock
5334
0
D
Employee Stock Option (Right to Buy)
13.17
2021-03-23
4
M
0
19313
0
D
2025-01-06
Common Stock
19313
0
D
The price in Column 4 is a weighted average. The prices actually ranged from $38.00 to $38.70, inclusive. The reporting person has provided the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4.
The price in Column 4 is a weighted average price. The prices actually ranged from $39.025 to $39.075, inclusive.
This option became fully exercisable on January 7, 2019.
This option became fully exercisable on January 6, 2020.
/s/ Kevin R. Karas, by Christopher Kortum, attorney-in-fact, pursuant to a POA previously filed with the SEC
2021-03-25